 Karin Zemski Berry
Concepts (182)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phospholipids | 8 | 2024 | 207 | 1.600 |
Why?
| | Phosphatidylethanolamines | 5 | 2013 | 74 | 1.250 |
Why?
| | Insulin Resistance | 7 | 2024 | 1164 | 1.210 |
Why?
| | Ceramides | 4 | 2024 | 104 | 1.030 |
Why?
| | Phosphatidylcholines | 3 | 2024 | 146 | 0.950 |
Why?
| | Sarcolemma | 1 | 2024 | 40 | 0.920 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 2017 | 137 | 0.910 |
Why?
| | Lipids | 6 | 2022 | 621 | 0.850 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 7 | 2016 | 167 | 0.680 |
Why?
| | Diabetes Mellitus, Type 2 | 5 | 2024 | 2433 | 0.650 |
Why?
| | Muscle, Skeletal | 4 | 2024 | 1624 | 0.620 |
Why?
| | Tandem Mass Spectrometry | 6 | 2024 | 456 | 0.620 |
Why?
| | Docosahexaenoic Acids | 5 | 2024 | 83 | 0.610 |
Why?
| | Arachidonate 5-Lipoxygenase | 2 | 2016 | 38 | 0.600 |
Why?
| | Plasmalogens | 3 | 2013 | 6 | 0.580 |
Why?
| | Isotope Labeling | 2 | 2009 | 73 | 0.560 |
Why?
| | Ozone | 1 | 2016 | 103 | 0.480 |
Why?
| | Optic Nerve | 1 | 2013 | 64 | 0.430 |
Why?
| | Macrophages, Alveolar | 1 | 2016 | 375 | 0.420 |
Why?
| | para-Aminobenzoates | 2 | 2010 | 6 | 0.410 |
Why?
| | Computational Biology | 1 | 2017 | 597 | 0.400 |
Why?
| | Oxidation-Reduction | 4 | 2024 | 1003 | 0.390 |
Why?
| | Retina | 1 | 2013 | 274 | 0.370 |
Why?
| | Fetal Blood | 2 | 2024 | 317 | 0.360 |
Why?
| | Placenta | 4 | 2024 | 719 | 0.340 |
Why?
| | Acrolein | 1 | 2007 | 23 | 0.280 |
Why?
| | Imaging, Three-Dimensional | 1 | 2011 | 529 | 0.280 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2024 | 190 | 0.250 |
Why?
| | Triglycerides | 5 | 2022 | 523 | 0.240 |
Why?
| | Glycerylphosphorylcholine | 1 | 2005 | 6 | 0.240 |
Why?
| | Obesity | 8 | 2024 | 2864 | 0.230 |
Why?
| | Methane | 1 | 2005 | 49 | 0.230 |
Why?
| | Free Radicals | 1 | 2005 | 103 | 0.230 |
Why?
| | Lung | 1 | 2017 | 3748 | 0.220 |
Why?
| | Diglycerides | 1 | 2024 | 61 | 0.220 |
Why?
| | Liposomes | 4 | 2010 | 168 | 0.220 |
Why?
| | Fatty Acids, Unsaturated | 3 | 2016 | 95 | 0.220 |
Why?
| | Symporters | 1 | 2023 | 54 | 0.210 |
Why?
| | Chromatography, Liquid | 3 | 2023 | 381 | 0.210 |
Why?
| | Hyperinsulinism | 1 | 2024 | 119 | 0.210 |
Why?
| | Mitochondrial Diseases | 1 | 2023 | 90 | 0.210 |
Why?
| | Oxygen | 2 | 2022 | 901 | 0.200 |
Why?
| | Glycerol | 1 | 2022 | 87 | 0.200 |
Why?
| | Animals | 13 | 2024 | 34647 | 0.200 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2023 | 138 | 0.200 |
Why?
| | Chromatography, High Pressure Liquid | 3 | 2010 | 488 | 0.200 |
Why?
| | Intra-Abdominal Fat | 1 | 2022 | 88 | 0.190 |
Why?
| | Overnutrition | 1 | 2022 | 30 | 0.190 |
Why?
| | Mass Spectrometry | 1 | 2005 | 663 | 0.190 |
Why?
| | Dietary Supplements | 2 | 2024 | 531 | 0.180 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2016 | 205 | 0.170 |
Why?
| | Adipose Tissue | 2 | 2022 | 589 | 0.170 |
Why?
| | Immunity | 1 | 2020 | 139 | 0.170 |
Why?
| | Mice | 10 | 2024 | 16620 | 0.170 |
Why?
| | Humans | 22 | 2024 | 128499 | 0.160 |
Why?
| | Cross-Sectional Studies | 3 | 2024 | 5045 | 0.160 |
Why?
| | Rats | 2 | 2024 | 5246 | 0.150 |
Why?
| | Heart Diseases | 1 | 2022 | 347 | 0.150 |
Why?
| | Cell Cycle Proteins | 2 | 2016 | 581 | 0.150 |
Why?
| | Lysophospholipids | 2 | 2008 | 68 | 0.140 |
Why?
| | Arachidonic Acid | 2 | 2009 | 114 | 0.140 |
Why?
| | Fetal Growth Retardation | 1 | 2022 | 543 | 0.130 |
Why?
| | Neutrophils | 3 | 2007 | 1192 | 0.130 |
Why?
| | Body Mass Index | 1 | 2024 | 2263 | 0.130 |
Why?
| | Female | 11 | 2024 | 68268 | 0.130 |
Why?
| | Biological Transport | 1 | 2017 | 396 | 0.120 |
Why?
| | Phenotype | 1 | 2024 | 3051 | 0.120 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2022 | 564 | 0.120 |
Why?
| | Molecular Structure | 2 | 2007 | 466 | 0.120 |
Why?
| | Sulfoglycosphingolipids | 1 | 2013 | 3 | 0.110 |
Why?
| | Cell Line | 2 | 2010 | 2741 | 0.110 |
Why?
| | Photoreceptor Cells, Vertebrate | 1 | 2013 | 26 | 0.110 |
Why?
| | Colitis | 1 | 2016 | 240 | 0.110 |
Why?
| | Pregnancy | 5 | 2024 | 6373 | 0.110 |
Why?
| | Retinal Pigment Epithelium | 1 | 2013 | 69 | 0.110 |
Why?
| | Mice, Inbred C57BL | 3 | 2023 | 5281 | 0.110 |
Why?
| | Prostatic Neoplasms | 1 | 2020 | 1016 | 0.100 |
Why?
| | Carnitine | 2 | 2024 | 76 | 0.100 |
Why?
| | Interferon-gamma | 1 | 2016 | 761 | 0.100 |
Why?
| | Sphingolipids | 2 | 2023 | 69 | 0.100 |
Why?
| | Culture Media, Conditioned | 2 | 2022 | 108 | 0.100 |
Why?
| | Middle Aged | 3 | 2024 | 30923 | 0.090 |
Why?
| | Organ Specificity | 1 | 2011 | 290 | 0.090 |
Why?
| | Cardiovascular Diseases | 1 | 2022 | 2001 | 0.080 |
Why?
| | 4-Aminobenzoic Acid | 1 | 2009 | 7 | 0.080 |
Why?
| | Male | 6 | 2024 | 63045 | 0.080 |
Why?
| | Eicosanoids | 2 | 2009 | 55 | 0.080 |
Why?
| | Arachidonate 12-Lipoxygenase | 1 | 2009 | 13 | 0.080 |
Why?
| | Arachidonate 15-Lipoxygenase | 1 | 2009 | 19 | 0.080 |
Why?
| | Apolipoproteins E | 1 | 2009 | 77 | 0.080 |
Why?
| | Macrophages, Peritoneal | 1 | 2009 | 90 | 0.080 |
Why?
| | Fetus | 2 | 2024 | 765 | 0.080 |
Why?
| | Monoglycerides | 1 | 2008 | 2 | 0.080 |
Why?
| | Peritonitis | 1 | 2009 | 81 | 0.080 |
Why?
| | Adult | 3 | 2024 | 35302 | 0.070 |
Why?
| | HL-60 Cells | 1 | 2007 | 33 | 0.070 |
Why?
| | Secretory Vesicles | 1 | 2007 | 25 | 0.070 |
Why?
| | Neutrophil Activation | 1 | 2007 | 78 | 0.070 |
Why?
| | Calcimycin | 1 | 2005 | 48 | 0.060 |
Why?
| | Ionophores | 1 | 2005 | 22 | 0.060 |
Why?
| | Calcium Signaling | 1 | 2007 | 233 | 0.060 |
Why?
| | Hydrocarbons | 1 | 2005 | 27 | 0.060 |
Why?
| | Atherosclerosis | 1 | 2009 | 403 | 0.060 |
Why?
| | Models, Molecular | 1 | 2010 | 1484 | 0.060 |
Why?
| | Lipid Peroxidation | 1 | 2005 | 149 | 0.060 |
Why?
| | Membrane Lipids | 1 | 2005 | 90 | 0.060 |
Why?
| | Ubiquinone | 1 | 2023 | 28 | 0.050 |
Why?
| | Aldehydes | 1 | 2005 | 138 | 0.050 |
Why?
| | Glucose Clamp Technique | 1 | 2024 | 194 | 0.050 |
Why?
| | Electron Transport | 1 | 2023 | 112 | 0.050 |
Why?
| | Choline | 1 | 2024 | 120 | 0.050 |
Why?
| | Models, Chemical | 1 | 2005 | 263 | 0.050 |
Why?
| | Isophane Insulin, Human | 1 | 2022 | 5 | 0.050 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2022 | 18 | 0.050 |
Why?
| | Signal Transduction | 1 | 2016 | 4825 | 0.050 |
Why?
| | Lysophosphatidylcholines | 1 | 2022 | 19 | 0.050 |
Why?
| | Arachidonic Acids | 1 | 2022 | 54 | 0.050 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2024 | 169 | 0.050 |
Why?
| | Membrane Transport Proteins | 1 | 2023 | 149 | 0.050 |
Why?
| | Acyltransferases | 1 | 2022 | 53 | 0.050 |
Why?
| | Adipokines | 1 | 2022 | 47 | 0.050 |
Why?
| | Adult Children | 1 | 2022 | 23 | 0.050 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2022 | 84 | 0.050 |
Why?
| | Subcutaneous Fat | 1 | 2022 | 74 | 0.050 |
Why?
| | Rheology | 1 | 2022 | 90 | 0.050 |
Why?
| | Aged, 80 and over | 1 | 2013 | 7057 | 0.050 |
Why?
| | Ultraviolet Rays | 1 | 2005 | 380 | 0.050 |
Why?
| | Dinoprostone | 1 | 2022 | 187 | 0.050 |
Why?
| | Fatty Acids | 1 | 2005 | 417 | 0.050 |
Why?
| | Interleukin-13 | 1 | 2022 | 144 | 0.050 |
Why?
| | Fetal Heart | 1 | 2022 | 55 | 0.050 |
Why?
| | Phosphates | 1 | 2022 | 169 | 0.050 |
Why?
| | Interleukin-8 | 1 | 2022 | 262 | 0.050 |
Why?
| | RNA, Small Interfering | 1 | 2023 | 573 | 0.050 |
Why?
| | Acute Disease | 1 | 2024 | 965 | 0.050 |
Why?
| | Cell Membrane | 1 | 2005 | 725 | 0.040 |
Why?
| | Cardiomegaly | 1 | 2022 | 168 | 0.040 |
Why?
| | Ranolazine | 1 | 2020 | 25 | 0.040 |
Why?
| | PPAR gamma | 1 | 2022 | 182 | 0.040 |
Why?
| | Macrophages | 1 | 2008 | 1464 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2023 | 2679 | 0.040 |
Why?
| | Ultrasonography, Prenatal | 1 | 2022 | 270 | 0.040 |
Why?
| | Athletes | 1 | 2024 | 407 | 0.040 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2020 | 216 | 0.040 |
Why?
| | Cell Line, Tumor | 1 | 2007 | 3178 | 0.040 |
Why?
| | Tumor Burden | 1 | 2020 | 284 | 0.040 |
Why?
| | Pregnancy Complications | 1 | 2024 | 491 | 0.040 |
Why?
| | Birth Weight | 1 | 2022 | 499 | 0.040 |
Why?
| | Erythrocytes | 1 | 2024 | 673 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2022 | 715 | 0.040 |
Why?
| | Young Adult | 2 | 2024 | 12349 | 0.040 |
Why?
| | Molecular Targeted Therapy | 1 | 2020 | 385 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1187 | 0.040 |
Why?
| | Lipid Metabolism | 1 | 2020 | 492 | 0.040 |
Why?
| | Dendritic Cells | 1 | 2020 | 477 | 0.030 |
Why?
| | Glucose | 1 | 2022 | 983 | 0.030 |
Why?
| | Mice, Knockout | 2 | 2016 | 2765 | 0.030 |
Why?
| | Dextran Sulfate | 1 | 2016 | 77 | 0.030 |
Why?
| | Ions | 1 | 2016 | 65 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2020 | 842 | 0.030 |
Why?
| | Aged | 1 | 2013 | 21976 | 0.030 |
Why?
| | Time Factors | 1 | 2005 | 6506 | 0.030 |
Why?
| | Biomarkers, Tumor | 1 | 2020 | 1179 | 0.030 |
Why?
| | Insulin | 1 | 2023 | 2316 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2016 | 1142 | 0.020 |
Why?
| | Brain | 1 | 2023 | 2624 | 0.020 |
Why?
| | Cells, Cultured | 2 | 2008 | 4017 | 0.020 |
Why?
| | Peritoneal Lavage | 1 | 2009 | 7 | 0.020 |
Why?
| | Phosphatidylglycerols | 1 | 2008 | 24 | 0.020 |
Why?
| | Organ Size | 1 | 2009 | 441 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2009 | 283 | 0.020 |
Why?
| | GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2007 | 17 | 0.020 |
Why?
| | Spleen | 1 | 2009 | 509 | 0.020 |
Why?
| | Type C Phospholipases | 1 | 2007 | 72 | 0.020 |
Why?
| | Cholesterol | 1 | 2008 | 406 | 0.020 |
Why?
| | Aorta | 1 | 2009 | 408 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2016 | 3947 | 0.020 |
Why?
| | Isoprostanes | 1 | 2005 | 5 | 0.020 |
Why?
| | Thromboxanes | 1 | 2005 | 16 | 0.020 |
Why?
| | Cannabinoid Receptor Modulators | 1 | 2005 | 7 | 0.020 |
Why?
| | Leukotrienes | 1 | 2005 | 34 | 0.020 |
Why?
| | Prostaglandins | 1 | 2005 | 85 | 0.020 |
Why?
|
|
Zemski Berry's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|